A CRISPR-Cas9 screen identifies LAPTM4A (lysosomal protein transmembrane 4 alpha) as a key host barrier against PRRSV

Zhan He1, Min Liu1, Nianqi Zhang1

  • 1Guangdong Laboratory for Lingnan Modern Agriculture, State Key Laboratory of Animal Disease Control and Prevention, Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, PR China.

Autophagy
|April 22, 2026
PubMed

Insights

Porcine reproductive and respiratory syndrome virus (PRRSV) degrades the LAPTM4A protein, a key regulator of autophagy and lysosomal function. This viral strategy disrupts host defense, promoting PRRSV replication and spread.

Area of Science:

  • Cell Biology
  • Virology
  • Molecular Biology

Background:

  • Porcine reproductive and respiratory syndrome virus (PRRSV) hijacks host cellular processes, including autophagy and lysosomal pathways, for replication.
  • The specific host factors and mechanisms PRRSV employs to manipulate the autophagy-lysosome axis are not fully understood.

Purpose of the Study:

  • To identify host factors involved in PRRSV's manipulation of the autophagy-lysosome axis.
  • To elucidate the molecular mechanisms by which PRRSV disrupts host antiviral defense pathways.

Main Methods:

  • Conducted a CRISPR-Cas9 knockout screen of 1,332 genes related to protein degradation, metabolism, and vesicular trafficking.
  • Utilized yeast two-hybrid screening to identify interactions between viral and host proteins.
  • Investigated the role of LAPTM4A in autophagy, lysosomal function, and antiviral defense.

Main Results:

  • Identified Lysosomal Protein Transmembrane 4 Alpha (LAPTM4A) as a crucial antiviral factor in the lysosomal pathway.
  • Demonstrated that PRRSV GP5 protein recruits NEDD4 and SQSTM1/p62 to induce K63-linked polyubiquitination and autophagic degradation of LAPTM4A.
  • Showed that LAPTM4A degradation activates AMPK-ULK1-LC3 signaling, promotes MTOR-lysosome colocalization, suppresses TFEB activity, and enhances viral replication.
  • Revealed that LAPTM4A maintains lysosomal homeostasis and provides broad antiviral protection by restraining excessive autophagy and promoting TFEB-mediated lysosomal gene expression.

Conclusions:

  • LAPTM4A is a critical regulator of lysosome-autophagy homeostasis and acts as an antiviral factor.
  • PRRSV employs a strategy to degrade LAPTM4A, thereby dismantling host antiviral defenses to facilitate infection.
  • Understanding this mechanism offers potential targets for therapeutic interventions against PRRSV and other RNA viruses.

Related Concept Videos

The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
1.0K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.1K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
46.2K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
14.5K